Ledger.Open graph →
SEC Form D · Amendment · filed November 17, 2017

Palleon Pharmaceuticals Inc

Offering
$48.3M
Sold
$20.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

John W. Hennessy · Waltham, MAExecStephen W. Hoffman · Waltham, MADirectorWilliam W. Burkoth · Waltham, MADirectorJames W. Broderick · Waltham, MAExec · DirectorJens W. Eckstein · Cambridge, MADirectorCharles I. Biltz, Jr · San Antonio, TXExec · DirectorSilbiano V. Gonzales, Jr · San Antonio, TXDirectorMichael V. Morykwas · San Antonio, TXExecFrank I. Dilazzaro · San Antonio, TXDirectorKaren W. Hong · Waltham, MADirectorJames W. Lee · Waltham, MADirectorCAVU Management LP · Fort Worth, TXExecCharles Tollinche · Chicago, ILExec · DirectorRobert G. Walton · Chicago, ILDirectorPatrick G. Fenton · Chicago, ILDirectorJens W. Eckstein · Cambridge, MADirectorKaren W. Hong · Waltham, MADirectorJames W. Lee · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗